Age-Related Diseases, Clinical Development, In vitro Biology, Proteomics, Metabolomics & Biomarkers, Videos & Webinars A Spotlight on Aging Webinar series 19 September 2023 Learn more
Age-Related Diseases, Articles & Whitepapers, Blog, Clinical Development, In vitro Biology, Proteomics, Metabolomics & Biomarkers Unlocking the Secrets of Healthy Aging: Prolonging Healthspan and Enhancing Quality of Life 19 September 2023 Learn more
Age-Related Diseases, Biologics, Blog iPSC and Age-Related Diseases: Case Study Age-Related Macular Degeneration 31 May 2022 Learn more
Age-Related Diseases, Articles & Whitepapers, In vitro Biology, Medicinal Chemistry, Neuroscience Discovery of Pyrazolo[1,5-a]pyrazin-4-ones as Potent and Brain Penetrant GluN2A-Selective Positive Allosteric Modulators Reducing AMPA Receptor Binding Activity 22 December 2021 Learn more
ADME/DMPK, Age-Related Diseases, Articles & Whitepapers PK and Metabolism of Lumiracoxib in Chimeric Humanized and Murinized FRG Mice 4 March 2021 Learn more
Age-Related Diseases, Articles & Whitepapers MANF: Pro-regenerative and Protective Effects from Osteoarthritis 3 March 2021 Learn more
![Discovery of Pyrazolo[1,5-a]pyrazin-4-ones as Potent and Brain Penetrant GluN2A-Selective Positive Allosteric Modulators Reducing AMPA Receptor Binding Activity](https://sciencepool.evotec.com/wp-content/uploads/elementor/thumbs/shutterstock_1306602358-neuron-pink-03-science-pool-scaled-qcxb9yjkq65hjxk5v5t8r79dsdck54h65vjs5ujgik.jpg "Discovery of Pyrazolo[1,5-a]pyrazin-4-ones as Potent and Brain Penetrant GluN2A-Selective Positive Allosteric Modulators Reducing AMPA Receptor Binding Activity")
